Skip to main content Skip to footer
American Family Children's Hospital
SHARE TEXT
 


Print Friendly Page

Protocol No. UW16009

Principal Investigator DeSantes, Kenneth

Phase I

Age Group Both

Scope Local

Sponsor Type Externally Peer-Reviewed; Institutional

Title Treatment of Relapsed or Refractory Neuroblastoma with Ex-Vivo Expanded and Activated Haploidentical NK Cells and Hu14.18-IL2

Applicable Disease Sites Anal; Bladder; Brain/Central Nervous System; Breast; Cervix; Colon and Rectum; Endocrine cancers; Esophagus; Gastrointestinal cancers, other; Genitourinary cancers, other; Head and Neck; Hematologic cancers, other; Ill-Defined Sites; Kidney; Liver; Lung; Melanoma/Skin cancer; Ovary; Pancreas; Sarcoma; Stomach; Thyroid; Unknown Sites; Uterus

Drugs Involved cpm (cyclophosphamide); ctx (cyclophosphamide); cyclophosphamide; cytoxan (cyclophosphamide); f-ara-amp (fludarabine); flamp (fludarabine); fludara (fludarabine); fludarabine; hu14.18-IL2 fusion protein; mesna; mesnex (mesna); neosar (cyclophosphamide)

Status Open

Participating Institutions UW Hospital and Clinics